J Korean Surg Soc.
2000 Oct;59(4):447-457.
Use of RT-PCR for Cytokeratin 19 to Detect Micrometastases in Bone Marrow of Follow-up Patients with Breast Cancer after Surgery
- Affiliations
-
- 1Department of Surgery, College of Medicine, Soonchunhyang University, Seoul, Korea.
- 2Department of Pediatrics, College of Medicine, Soonchunhyang University, Seoul, Korea.
- 3Department of Internal Medicine, College of Medicine, Soonchunhyang University, Seoul, Korea.
Abstract
-
PURPOSE: We have previously reported that the reverse transcriptase-polymerase chain reaction
(RT-PCR) for cytokeratin 19 (CK 19) is a highly sensitive and specific method for detecting micrometas
tases in the bone marrow of patients with primary breast cancer. Thus, we conducted this study to identify
occult metastatic cells in the bone marrow of follow-up patients with breast cancer by using the RT-PCR
for cytokeratin 19 after surgery. METHODS: We studied 42 patients with breast cancer who had no evidence
of relapse, 3 patients who had a local relapse, and 7 patients who had distant metastases.
Bone-marrow aspirates were taken from the single posterior iliac crest under local anesthesia
anesthesia at a median of 45 months after surgery. RT-PCR for CK19 was done by using two
30-cycle rounds with nested primers. RESULTS: Occult metastases were found in 23% of the
52 breast-cancer patients. None of the bone-marrow aspirates showed any evidence of tumor
involvement by using conventional cytology. RT- PCR was positive for CK 19 in 19% of the
42 patients without relapse, and in 40% of the 10 patients with local or distant relapse.
CONCLUSION
RT-PCR for CK 19 is a sensitive method for detecting tumor cells in the bone
marrow of follow-up patients with breast cancer after surgery. This assay may be useful in
detecting metastastic disease, as well as in monitoring the effectiveness of systemic therapy.
However, a large study with long-term follow-up is required in order to clarify its clinical
significance and usefulness.